BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21515443)

  • 1. Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.
    Tiodorovic-Zivkovic D; Argenziano G; Catricalà C; Ferrara G; Giorgio CM; Moscarella E; Zalaudek I
    Eur J Dermatol; 2011; 21(3):410-1. PubMed ID: 21515443
    [No Abstract]   [Full Text] [Related]  

  • 2. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
    Florin V; Vercambre-Darras S; Piette F; Mortier L
    Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical imiquimod in the treatment of metastatic melanoma to skin.
    Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
    Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Fisher GH; Lang PG
    Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
    Suchin KR; Junkins-Hopkins JM; Rook AH
    Arch Dermatol; 2002 Sep; 138(9):1137-9. PubMed ID: 12224972
    [No Abstract]   [Full Text] [Related]  

  • 8. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma.
    Bong AB; Bonnekoh B; Franke I; Schön M; Ulrich J; Gollnick H
    Dermatology; 2002; 205(2):135-8. PubMed ID: 12218228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of invasive melanoma with topical imiquimod.
    Moon SD; Spencer JM
    J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
    Chapman MS; Spencer SK; Brennick JB
    Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Topical treatment of melanoma skin metastases with imiquimod].
    Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
    Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
    Ellis LZ; Cohen JL; High W; Stewart L
    Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy.
    Jensen JM; Egberts F; Proksch E; Hauschild A
    Acta Derm Venereol; 2005; 85(6):550-1. PubMed ID: 16396815
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of imiquimod to minimize the surgical defect when excising invasive malignant melanoma surrounded by extensive melanoma in situ, lentiginous type.
    Missall TA; Fosko SW
    Dermatol Surg; 2009 May; 35(5):868-74. PubMed ID: 19389091
    [No Abstract]   [Full Text] [Related]  

  • 16. Lentiginous melanoma in situ treatment with topical imiquimod: need for individualized regimens.
    Missall TA; Hurley MY; Fosko SW
    Arch Dermatol; 2010 Nov; 146(11):1309-10. PubMed ID: 21079078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Initial success with topical immunomodulators. A creme for skin cancer? (interview by Renate Jackle)].
    Hengge U
    MMW Fortschr Med; 2001 May; 143(21):11. PubMed ID: 11420824
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowen's disease of the penis treated with topical imiquimod 5% cream.
    Taliaferro SJ; Cohen GF
    J Drugs Dermatol; 2008 May; 7(5):483-5. PubMed ID: 18505144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.